Environmental & Occupational Health Faculty
Publications

Environmental and Occupational Health

6-27-2019

Risk of Cancer Death Among White, Black, and Hispanic
Populations in South Florida
Paulo S. Pinheiro
University of Miami School of Medicine, ppinheiro@med.miami.edu

Karen E. Callahan
University of Nevada, Las Vegas, karen.callahan@unlv.edu

Tulay Koru-Sengul
University of Miami School of Medicine

Justine Ransdell
University of Miami School of Medicine

Layla Bouzoubaa
University of Miami School of Medicine
Follow this and additional works at: https://digitalscholarship.unlv.edu/env_occ_health_fac_articles
Part of the Clinical Epidemiology Commons
See next page for additional authors

Repository Citation
Pinheiro, P. S., Callahan, K. E., Koru-Sengul, T., Ransdell, J., Bouzoubaa, L., Brown, C. P., Kobetz, E. (2019).
Risk of Cancer Death Among White, Black, and Hispanic Populations in South Florida. Preventing Chronic
Disease, 16 1-10. Centers for Disease Control and Prevention.
http://dx.doi.org/10.5888/pcd16.180529

This Article is protected by copyright and/or related rights. It has been brought to you by Digital Scholarship@UNLV
with permission from the rights-holder(s). You are free to use this Article in any way that is permitted by the
copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from
the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/
or on the work itself.
This Article has been accepted for inclusion in Environmental & Occupational Health Faculty Publications by an
authorized administrator of Digital Scholarship@UNLV. For more information, please contact
digitalscholarship@unlv.edu.

Authors
Paulo S. Pinheiro, Karen E. Callahan, Tulay Koru-Sengul, Justine Ransdell, Layla Bouzoubaa, Clyde P.
Brown, and Erin Kobetz

This article is available at Digital Scholarship@UNLV: https://digitalscholarship.unlv.edu/env_occ_health_fac_articles/
432

PREVENTING CHRONIC DISEASE
PUBLIC

HEALTH

RESEARCH,

PRACTICE,

Volume 16, E83

AND

POLICY
JUNE 2019

ORIGINAL RESEARCH

Risk of Cancer Death Among White, Black, and
Hispanic Populations in South Florida
Paulo S. Pinheiro, MD, PhD1; Karen E. Callahan, MPH2; Tulay Koru-Sengul, PhD1; Justine Ransdell, BSc3;
Layla Bouzoubaa, MSPH1; Clyde P. Brown, DrPH4; Erin Kobetz, PhD1
Accessible Version: www.cdc.gov/pcd/issues/2019/18_0529.htm

Suggested citation for this article: Pinheiro PS, Callahan KE,
Koru-Sengul T, Ransdell J, Bouzoubaa L, Brown CP, et al. Risk
of Cancer Death Among White, Black, and Hispanic Populations
in South Florida. Prev Chronic Dis 2019;16:180529. DOI: https://
doi.org/10.5888/pcd16.180529.
PEER REVIEWED
Summary
What is already known on this topic?
Compared with white Americans, cancer mortality rates are higher among
black Americans and lower among Hispanic Americans.
What is added by this report?
White and black residents of South Florida have lower cancer mortality
rates than their national counterparts, and the advantage for black South
Floridians results from the large number of Afro-Caribbean residents, who
have low risk for cancer mortality. Hispanics in South Florida, most of
whom are Cuban, have higher mortality rates for most cancers than their
national counterparts.

binomial regression to determine mortality rate ratios to compare
South Florida’s cancer mortality rates with those of the rest of the
nation.

Results
We analyzed 53,837 cancer deaths. Per 100,000 population, cancer mortality rates in South Florida were similar among white (173
per 100,000) and black (176 per 100,000) men and among white
and black women (133 for both), and they were lowest among
Hispanic men (151 per 100,000) and women (93 per 100,000).
However, compared with their counterparts nationally, Hispanic
residents in South Florida had higher cancer mortality rates,
largely driven by Cuban residents, and mortality rates among
white and black residents, especially male residents, were substantially lower. Liver cancer rates were high among white and Puerto
Rican “baby boomers”; lung cancer mortality was low among all
groups except Cuban men; cervical cancer was high among white,
black, and Puerto Rican women.

Conclusion

Abstract

Cancer patterns are not monochromatic in all US regions; South
Florida is distinctive. Meeting the needs of an aging diverse population presents challenges for all major metropolitan areas. Expanding surveillance, increasing minority participation in clinical
trials, and investing in culturally specific community-based health
promotion must continue.

Background

Introduction

What are the implications for public health practice?
Effective cancer prevention and control efforts should be specific to populations to account for diversity.

The cancer burden in South Florida, with a population of more
than 6 million with a heavily Hispanic and large Afro-Caribbean
population, has not been quantified.

Methods
We analyzed 2012–2016 cancer mortality data from South Florida
for white, Hispanic, and black populations with disaggregation for
Cuban, Puerto Rican, South American, African American, and
Afro-Caribbean groups. We calculated cancer site-specific and allsites combined age-adjusted mortality rates, and we used negative

As cancer prevalence rises among the increasingly diverse US
population, targeted and culturally specific community-based cancer prevention and control efforts are required. Ideally, these will
be based on the most current knowledge of the population-specific cancer burden, including disparities, for a specific geographic
area (1). South Florida is the eighth largest metropolis in the
United States and is growing; it has more than 6 million residents
and comprises nearly one-third of Florida’s total population. South
Florida is a gateway to Latin America and the Caribbean, and
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demographics reflect this: 44% of residents are Hispanic, 32% are
white, and 21% are black (2). The diversity extends intra-racially;
33% of black residents in South Florida are Afro-Caribbean, many
from Haiti and Jamaica (2). Likewise, the Hispanic population in
South Florida, born primarily outside of the continental United
States, differs vastly from the predominantly Mexican-origin Hispanic US population. Cubans are the largest Hispanic group in
South Florida, also home to large South American, Central American, and Puerto Rican populations (2).
Cancer is the leading cause of death for Hispanics and Afro-Caribbeans in Florida (3,4) as well as elsewhere in the United States
(5,6). Yet no studies to date have analyzed cancer death rates in
South Florida, the catchment area of the Sylvester Comprehensive
Cancer Center at the University of Miami, which includes
Broward, Miami-Dade, Monroe, and Palm Beach counties. Thus,
our objective was to characterize patterns of cancer deaths by race/
ethnicity in South Florida and compare rates between South Florida and the United States. We hypothesized that the cancer mortality rates of metropolitan areas would differ from those of the
United States as a whole.

Methods
We analyzed 5 years of cancer mortality data (January 1, 2012,
through December 31, 2016) for Florida residents in the MiamiDade-Broward-Palm Beach metropolitan statistical area. Data
were obtained from the Florida Department of Health Vital Statistics for this cross-sectional study. Deaths from Monroe County (n =
956) were not included because of lack of corresponding population-specific denominators. Cancer sites were coded according to
the International Classification of Diseases, 10th Revision. We
analyzed common causes of cancer death (lung, breast, prostate,
colorectum, pancreas, endometrium, ovary, and liver); cancers
with high mortality rates among Hispanic and black populations
(cervical, stomach, and multiple myeloma); and all-sites-combined (ie, deaths from all cancers). Because of the high prevalence of premenopausal breast cancer among black women (3,5),
breast cancer was analyzed in 2 categories, using an age threshold
of 50 to approximate premenopausal and postmenopausal breast
cancer (7). Liver cancer is common among minorities (8), and recent reports from California (9) and New York (5) have indicated
significant differences between people born before 1945 and the
1945–1965 birth cohort, which is subject to the Centers for Disease Control and Prevention’s (CDC’s) recommendation for onetime hepatitis C (HCV) testing because of high HCV prevalence
(10). To approximate these 2 groups, we analyzed liver cancer
rates for people aged 50 to 69 years and for those aged 70 years or
older.

We carefully examined codes for race/ethnicity and birthplace, including text fields, to accurately classify race/ethnicity (3,5,11).
We analyzed the total Hispanic population and separately analyzed the Cuban, Puerto Rican, South American, and Other Hispanic (Mexican, Dominican, Central American, and Spaniard)
populations. We analyzed the total non-Hispanic black population
(hereafter referred to as black) and separately analyzed the African American (black, born in the United States) and Afro-Caribbean (black, born in the Caribbean) populations. Finally, we analyzed the non-Hispanic white population (hereafter referred to as
white). Black decedents born in Africa or other countries not studied here were included in the aggregate black rates but not studied
separately (n = 225). Also, because of low numbers, American Indian/Alaska Native, Asian, and Pacific Islander decedents were
not included in this study (n = 714).
We obtained population denominators for the tri-county region for
each year from 2012 to 2016 from the US Census Bureau’s
American Community Survey (2), assembled into populations corresponding with numerator data and aggregated. Hispanics who
were “not otherwise specified” from the census data (less than
2%) were bridged to each study population proportionately by age
group and sex.
Sex-specific, annualized, age-standardized (2000 US standard
population) cancer mortality rates for 2012–2016 were calculated
per 100,000 people using 18 age group bands, all 5-year except the
last (ie, aged ≥85).
For direct comparison with South Florida estimates, national cancer mortality rates for 2012 through 2014 were obtained from
CDC (11) (South Florida data were restricted to these 3 years for
comparability). Age-adjusted site-specific mortality rate ratios
(MRRs) and corresponding 95% confidence intervals (CIs) were
computed for white, black, and Hispanic populations in South
Florida, using their corresponding racial/ethnic counterparts nationally as the reference population. To account for the large number of foreign-born black decedents in South Florida, MRRs for
the aggregate black as well as the exclusively African American
populations were both computed. MMRs were computed using
negative binomial regression. Models included decedents aged 35
or older, except for prostate cancer and multiple myeloma, which
included decedents aged 45 or older.
Data management and statistical analyses were performed using
SPSS version 22.0 (IBM Corporation) and SAS version 9.4 (SAS
Institute, Inc). Ethical review resulting in exempt status was obtained from the University of Miami institutional review board.
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Results
In 2012–2016, cancer was the primary cause of death for 53,837
South Florida residents, of whom 29,050 were white (54%),
16,918 Hispanic (31%), and 7,869 black (15%). The median age
of white decedents was 48 years; Hispanic decedents, 38 years;
and black decedents, 31 years. Ninety-five percent of Hispanic,
41% of black, and 12% of white decedents were born outside the
continental US (including Puerto Rico) (Table 1).
Lung cancer was the leading cause of cancer death for all male
groups except Afro-Caribbeans and other Hispanics, for whom
prostate cancer was the leading cause followed by lung and
colorectal cancers. Prostate and colorectal cancers were the second
and third leading causes of cancer death for all other male groups,
apart from Puerto Ricans for whom liver cancer was the second
leading cause of cancer death, followed by prostate. Among female decedents, lung and breast cancers were the first or the
second leading cause of cancer death in all groups, followed by
colorectal cancer as the third, except for Afro-Caribbeans, for
whom both breast and colorectal cancers preceded lung cancer
(Table 2).

higher among Hispanic males (MRR, 1.11; 95% CI, 1.08–1.14)
and approximately equivalent among Hispanic females. Conversely, compared with their corresponding counterparts nationally, risk of cancer death in South Florida was significantly lower
among white males (10% lower), white females (5% lower), black
males (27% lower), and black females (19% lower) (Table 3).
Comparison of South Florida’s African American population to
the overall US black population reduced the risk advantage from
27% to only 8% lower mortality for males, and no significant difference was found between African American females in South
Florida and black females in the United States (Table 3).
Compared with national data, risk of death from lung cancer was
20% lower for white and African American males in South Florida but 46% and 13% higher for Hispanic males and females, respectively. Compared with their US counterparts, the cervical cancer mortality rate in South Florida was 24% higher among whites
and 71% higher among African Americans (Table 3). Furthermore, white males had a 19% lower prostate cancer rate and a
10% lower colorectal cancer rate, and white females had a 12%
lower colorectal cancer rate and a 6% lower breast cancer rate than
their national counterparts.

African American male and female decedents had the highest allsites-combined cancer mortality rate among all groups, as well as
the highest rates for most cancers. Compared with white male and
female decedents in South Florida, all 4 disaggregated Hispanic
groups as well as Afro-Caribbeans had lower overall rates. Hispanics in aggregate had significantly higher mortality rates than
white South Floridians only for stomach (male and female) and
prostate cancers (P < .05). Afro-Caribbeans had significantly higher rates compared with whites for stomach, prostate, multiple myeloma, premenopausal breast, and endometrial cancers, but lower
rates for most other cancers, particularly lung cancer (Table 2).

The risk of liver cancer mortality among white males and females
in the age 50–69 group was significantly higher than their US
counterparts (23% and 28% higher in males and females, respectively). For Hispanics aged 50 to 69 years, compared with their US
counterparts, substantial risk of death for lung cancer, prostate
cancer (16% higher), pancreatic cancer in males (15% higher), and
colorectal cancer in females (15% higher) was offset by a reduced
risk of liver cancer mortality, 52% and 44% lower for males and
females, respectively. Even among decedents aged 70 years or
older, liver cancer mortality was 36% lower for Hispanic men and
30% lower for Hispanic women than it was nationally (Table 3).

For Hispanics, considerable heterogeneity was found in cancer
mortality rates. Liver cancer among Puerto Rican male decedents
was 15.0 per 100,000, compared with the lower rate of 6.4 among
Cubans and a rate of 8.8 per 100,000 among white decedents (reference group) in South Florida. Conversely, lung cancer rates for
Cuban male decedents were higher than for white male decedents,
45.0 compared with 42.4 per 100,000, whereas all female Hispanic groups and male South American decedents and other Hispanic
decedents had markedly lower lung cancer rates than whites.
Cuban decedents also had high colorectal cancer rates. Low mortality rates for most cancers were observed in South Americans
and the heterogeneous other Hispanics, except for stomach, prostate, and liver (especially aged ≥70 y) cancers (Table 2).

Discussion

In comparison with the overall US Hispanic population, the allsites-combined risk of cancer death in South Florida was 11%

Although South Florida cancer patterns generally align with the
epidemiology of cancer in the United States (ie, highest rates for
African Americans, lowest rates for Hispanics, and rates for
whites in between [5,12,13]), metropolitan-area–specific cancer
mortality rate disparities are evident. The densely populated and
increasingly diverse South Florida region has several unique aspects to its cancer burden.
Contrary to typical findings in the United States, no disparity in
overall cancer mortality was found between South Florida’s aggregate black and white populations. Moreover, compared with
their counterparts nationally, white and black populations in South
Florida had lower cancer mortality rates and Hispanics had signi-
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ficantly higher rates. Careful scrutiny of the unique racial/ethnic
composition of South Florida’s black and Hispanic populations,
combined with a portrayal of the specific characteristics of the
white population, can provide perspective on these findings.
In this study, the low rates of cancer mortality among South Florida’s black population are almost entirely driven by the inclusion
of low-risk Afro-Caribbeans, who make up 33% of South
Florida’s black (and 7% of the total) population (2). Analyzed separately, African Americans in South Florida experience cancer
mortality rates similar to those of African Americans in the United
States, with one notable exception: the lung cancer mortality rate
was 20% lower than among their black counterparts nationally, an
unexpected but encouraging finding. Although it is possible that
African American men in South Florida have a low prevalence of
current and/or past smoking, this information is not currently
available by racial/ethnic group at a local level. Research is warranted, as lung and other tobacco-driven cancers account for a sizable proportion of all cancer deaths. Among Afro-Caribbeans in
South Florida, the lower cancer mortality is consistent with prior
studies from Florida (3,4) and New York (5). Likewise, the previously reported (3,5) higher race-specific rates among both AfroCaribbean and African American populations for endometrial,
prostate, premenopausal breast, and multiple myeloma cancers
were confirmed for South Florida’s black population in this study.
South Florida’s 33% white population had lower rates than their
counterparts nationally for all 4 leading causes of cancer death:
lung, prostate, breast, and colorectal. Socioeconomic indicators
likely explain this finding. The older white population had a median household income of $79,400 and a 67% prevalence of college
education during the study period, higher than the national
$72,000 and 54%, respectively. The favorable impact of higher socioeconomic status on cancer indicators has been well documented (14–16). Higher income and education level in the United
States have generally been linked to lower prevalence of cancer
risk factors, including obesity (17) and smoking (18), resulting in
lower cancer incidence and better access to quality health care
(19), including cancer screening and high-quality cancer treatment. In South Florida, lower incidence and higher survival combined likely explain the lower mortality rates among whites. Nonetheless, the overall cancer burden is high, with nearly 6,000
deaths annually, because of the large number of older whites in the
region. Moreover, the markedly higher liver cancer mortality
among the white “baby boomers” (ie, roughly equivalent to people
aged 50–69 years, approximating the cohort with high HCV prevalence) in South Florida merits special attention. Priority should
be placed on increasing compliance with one-time screening for
people born between 1945 and 1965 as recommended by CDC,

given that early identification and treatment of HCV infection can
prevent liver cancer (10).
The largest racial/ethnic group in South Florida is Hispanic, comprising 45% of the total population. The Hispanic cancer mortality rate in this region is predominantly driven by the Cuban population, who are not only older (median age among Hispanics, 43 y)
but also have higher overall cancer mortality than other Hispanic
groups (4). Cubans are appreciably distinct from other Hispanic
groups, with a comparatively higher burden of colorectal, lung,
prostate, and breast cancers but markedly lower rates of cancers
caused by infectious agents (ie, cervical, liver, and stomach). Lung
cancer rates among Cuban males in South Florida surpass even
those of whites, which may reflect the previously documented
high prevalence of smoking among Cuban males (20). Conversely,
liver cancer mortality is low for Cubans, with patterns distinct
from other racial/ethnic groups in South Florida. Cubans appear to
have neither the increased susceptibility for HCV-related liver
cancer documented for many Americans in the 50–69 age range,
nor the high rates typically seen among immigrant Hispanics older
than 70. In contrast, Puerto Rican men in South Florida have a
high liver cancer mortality rate; this is true both for those aged 50
to 69 years, concordant with the high prevalence of HCV among
Puerto Ricans (21,22), and for those older than 69 years, consistent with the liver cancer mortality profile for Puerto Ricans in
New York (5). Notably, neither Hispanics in general, nor Puerto
Ricans in particular, are prioritized as a target group for intervention in the current National Viral Hepatitis Plan (9); this oversight
should be re-examined.
The high prostate cancer mortality rate among Hispanics compared with whites in South Florida and among African Americans
in South Florida in relation to US blacks is puzzling. Research is
needed to ascertain whether this stems from a truly higher risk of
aggressive prostate cancer among these groups or from survival
disparities resulting from differential access to quality health care
for prostate cancer, which requires a complex treatment protocol
(23).
Our population-based study benefits from its accurate disaggregation of Hispanic and black decedents into distinct groups with
unique characteristics that affect their cancer burden, accomplished by having more than 99% of exact birthplace information
and specific race/ethnicity codes. Nonetheless, the limitations customarily found in descriptive epidemiological studies apply.
Neither risk factor data nor screening and treatment information at
the individual level are available from mortality data. We examined cancer mortality, a function of cancer incidence and survival. Although our results are consistent with previously reported
cancer incidence patterns for Hispanic groups (24), limited health
care access and poor health care quality for some Hispanics may
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have resulted in poor cancer survival, thus affecting the mortality
burden. Unfortunately, the accuracy of survival data among the
foreign-born is prone to biases arising from passive follow-up
methods in cancer registries and missing information on birthplace or Hispanic group (25,26). Future studies should attempt to
improve survival estimation methods for foreign-born, mostly
minority populations.
This study shows heterogeneity in the cancer profile of South
Florida, indicated by examining differences by distinct racial/ethnic groups: the divergent liver cancer burden between Cuban and
Puerto Rican males is one such example. Addressing the cancer
prevention and control needs of this diverse population requires
leveraging this information in all community outreach and engagement efforts, which could include targeted smoking interventions
for Cuban men, HCV testing and antiviral treatment especially for
Puerto Rican men and white “baby boomers,” and a continued focus on cervical cancer screening among all South Florida women.
Moreover, researchers have a unique opportunity in South Florida
to study the biologic and genetic mechanisms driving race-specific vulnerability for certain cancers among South Florida’s black
population, given its 2 distinct birthplace cohorts, African Americans and Afro-Caribbeans.
Systematic collection of population-specific data taking into account the area’s extreme heterogeneity, as occurs in other equally
diverse areas of the country such as California (27) and New York
City (28), is lacking in Florida. Although some group-specific cancer research has been conducted in the area, these studies relied
primarily on relatively small samples (29,30). Cubans are most
disadvantaged by this gap in surveillance, as general data collected on US Hispanics is insufficient for meeting their needs. The
young composition of South Florida’s burgeoning population,
which comprises primarily Hispanics and blacks, provides opportunities for community-based and culturally specific lifestyle interventions, especially among socioeconomically disadvantaged
groups, including Central Americans and Haitians, to control
South Florida’s future cancer burden. The unique cancer control
challenges facing South Florida, like other large US metropolitan
areas, require expansion of population-specific surveillance, increased minority participation in clinical trials, and continued investment in community health education and promotion.
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Tables
Table 1. Population Characteristics, Study on Patterns of Cancer Deaths by Race/Ethnicity in South Florida, 2012–2016
Population Data (2)
Characteristic

Total
Population

Median Household
Income of Population, $

Cancer Data
Median Age of
Population, y

No. of Cancer
Deaths

Foreign-Born
Decedents, %a

Top Country of Birth of
Decedents, %

White

1,889,467

79,400

48

29,050

12

United States, 88

Black, allb

1,237,215

46,700

31

7,869

41

United States, 59

African American

811,825

45,000

24

4,633

0

United States, 100

Afro-Caribbean

403,273

48,000

42

3,011

100

Haiti, 48

Hispanic, all

2,601,132

55,500

38

16,918

95

Cuba, 63

Cuban

1,107,542

54,100

43

10,920

98

Cuba, 98

South American

556,275

60,000

38

2,670

99

Colombia, 38

Puerto Rican

241,947

59,000

33

1,220

79

Puerto Rico, 79

Other Hispanicc

695,368

51,225

33

2,108

91

Nicaragua, 23

a

Born outside of the 50 US states; includes birth on Island of Puerto Rico.
Includes people of black/African descent not born in Caribbean countries or the United States.
c
Includes decedents from Mexico, Central America, the Dominican Republic, and Spain.
b

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
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Table 2. Age-Adjusteda Mortality Rates for Selected Cancer Sites, Study on Patterns of Cancer Deaths by Race/Ethnicity in South Florida, 2012–2016
Black
White

All Black

Cancer type

African
American

Hispanic
AfroCaribbean

All Hispanic

Puerto Rican

South
American

Other
Hispanicb

3.9 (3.2–4.7)

7.4 (5.6–9.7)

5.2 (3.6–7.2)

16.0
(14.6–17.5)

13.1
(10.5–15.9)

13.0
(10.2–16.4)

6.4 (5.5–7.4) 8.3 (6.2–10.8)

10.3
(7.8–13.4)

Cuban

Age-Adjusted Mortality Rate Per 100,000 (95% Confidence Interval)

Male
Stomach

2.9 (2.5–3.3)

Colorectal

15.4
(14.5–16.5)

7.8 (6.5–9.4) 7.8 (5.9–10.0) 7.8 (5.9–10.4)

4.9 (4.3–5.6) 6.7 (4.2–10.2)

19.6
(17.5–21.9)

22.6
(19.5–26.1)

15.4
(12.7–18.6)

15.0
(13.9–16.1)

12.4
(9.0–16.6)

Liverc

8.8 (8.1–9.5) 9.6 (8.2–11.2)

11.2
(9.1–13.7)

7.0 (5.2–9.4)

7.6 (6.9–8.4)

14.9
(11.1–19.7)

Aged 50–69 y

4.5 (4.0–5.0)

4.0 (3.3–4.9)

5.7 (4.5–7.2)

1.9 (1.2–3.3)

3.0 (2.5–3.4)

6.2 (4.2–8.9)

2.6 (2.1–3.3)

1.4 (0.8–2.3)

4.5 (3.2–6.0)

Aged ≥70 y

4.0 (3.6–4.5)

4.4 (3.3–5.7)

4.5 (2.9–6.4)

3.7 (2.3–5.8)

4.4 (3.8–5.0) 8.5 (5.4–12.6)

3.6 (2.9–4.3)

6.5 (4.5–8.9)

5.7 (3.5–8.4)

Pancreas

13.7
(12.8–14.6)

10.1
(8.6–11.8)

13.0
(10.6–15.7)

6.9 (5.2–9.3)

11.0
(10.0–11.9)

10.4
(7.2–14.5)

11.5
(10.3–12.8)

Lung

42.4
(40.9–44.0)

33.9
(31.1–36.9)

47.8
(43.1–52.8)

18.1
(15.3–21.6)

36.3
(34.6–38.0)

31.9
(26.1–38.7)

45.0
(42.7–47.5)

20.6
(17.3–24.2)

19.4
(15.6–23.7)

Prostate

14.6
(13.8–15.5)

37.9
(34.6–41.3)

39.9
(35.2–45.0)

34.4
(30.0–39.3)

17.7
(16.4–18.9)

13.7
(9.6–18.7)

18.1
(16.7–19.7)

15.9
(12.8–19.5)

23.6
(19.0–28.8)

Multiple
myeloma

3.0 (2.6–3.4)

6.7 (5.4–8.1) 7.8 (5.9–10.1)

5.4 (3.9–7.6)

3.5 (3.0–4.1)

5.1 (2.9–8.2)

2.9 (2.3–3.6)

3.9 (2.6–5.7)

5.8 (3.8–8.2)

All-sites- d
combined

11.1 8.7 (6.3–11.5)
(8.8–13.9)

172.8
175.5
206.3
137.6
150.6
151.4
163.5
131.6
130.4
(169.7–176.1) (168.8–182.2) (196.1–216.7) (128.8–147.0) (147.2–154.2) (138.0–165.6) (158.9–168.2) (123.0–140.6) (120.4–140.8)

Female
Stomach

1.5 (1.2–1.8)

4.6 (3.8–5.5)

4.9 (3.6–6.3)

4.4 (3.3–6.3)

2.8 (2.4–3.2)

2.5 (1.3–4.3)

2.1 (1.6–2.7)

4.5 (3.3–5.9)

4.0 (2.8–5.4)

10.5
(9.8–11.4)

13.9
(12.5–15.5)

17.5
(15.1–20.1)

10.9
(9.2–13.3)

10.1
(9.4–10.9)

10.1
(7.4–13.4)

12.0
(10.9–13.2)

7.1 (5.6–8.9)

7.8 (6.1–9.8)

Liverc

3.8 (3.3–4.3)

4.3 (3.5–5.2)

5.2 (4.0–6.6)

3.3 (2.4–5.1)

4.2 (3.7–4.7)

4.7 (2.8–7.3)

3.6 (3.0–4.3)

5.1 (3.9–6.7)

6.4 (4.9–8.2)

Aged 50–69 y

1.5 (1.2–1.8)

1.7 (1.3–2.2)

2.6 (1.8–3.5)

0.9 (0.5–2.4)

1.1 (0.8–1.3)

0.7 (0.2–1.8)

0.9 (0.6–1.4)

1.0 (0.6–1.7)

1.6 (1.0–2.5)

Aged ≥70 y

2.1 (1.8–2.5)

2.3 (1.7–3.0)

2.3 (1.5–3.4)

2.0 (1.3–3.7)

2.9 (2.5–3.3)

4.0 (2.3–6.5)

2.3 (1.9–2.8)

3.9 (2.7–5.3)

4.5 (3.2–6.1)

10.0
(9.3–10.8)

10.1
(8.9–11.5)

12.7
(10.6–15.0)

7.3 (5.9–9.5)

7.1 (6.5–7.8) 8.2 (5.8–11.3)

7.2 (6.4–8.1)

7.2 (5.8–9.0)

7.0 (5.4–8.9)

Lung

34.8
(33.4–36.1)

18.5
(16.8–20.3)

28.8 9.1 (7.5–11.3)
(25.7–32.1)

14.4
(13.5–15.3)

14.1
(10.8–18.1)

16.5
(15.3–17.9)

14.0 9.7 (7.8–11.8)
(12.0–16.4)

Breast

20.2
(19.0–21.4)

25.7
(23.7–27.7)

30.7
(27.6–34.0)

20.5
(18.1–23.5)

14.6
(13.7–15.5)

16.2
(12.7–20.3)

15.5
(14.2–16.9)

12.4
(10.6–14.5)

13.1
(11.0–15.4)

Premenopausale

3.5 (2.9–4.3)

5.3 (4.4–6.4)

5.4 (4.1–7.0)

5.2 (4.0–7.2)

2.3 (1.9–2.7)

1.9 (0.8–3.5)

2.2 (1.6–3.2)

2.3 (1.6–3.2)

2.6 (1.8–3.6)

Postmenopausal

16.6
(15.7–17.6)

20.3
(18.6–22.1)

25.3
(22.4–28.3)

15.3
(13.3–17.9)

12.3
(11.5–13.2)

14.3
(11.0–18.3)

13.3
(12.2–14.5)

10.1
(8.5–12.1)

10.5
(8.7–12.7)

Cervix

2.8 (2.3–3.3)

4.0 (3.2–4.8)

4.9 (3.7–6.4)

3.0 (2.1–4.6)

1.9 (1.6–2.3)

2.9 (1.6–4.8)

1.8 (1.4–2.5)

1.9 (1.2–2.8)

1.9 (1.2–2.9)

Endometrium

4.3 (3.8–4.8) 9.2 (8.1–10.5) 9.8 (8.0–11.7) 8.6 (7.1–10.7)

3.8 (3.3–4.3)

4.3 (2.6–6.6)

4.0 (3.3–4.7)

3.1 (2.2–4.2)

4.3 (3.1–5.8)

Colorectal

Pancreas

a

Adjusted to the US 2000 standard population.
Includes decedents from Mexico, Central America, the Dominican Republic, and Spain.
c
Includes all ages.
d
All-sites-combined includes all cancers, including those not listed here.
e
Menopausal status approximated by use of age threshold of 50.
b

(continued on next page)
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(continued)
Table 2. Age-Adjusteda Mortality Rates for Selected Cancer Sites, Study on Patterns of Cancer Deaths by Race/Ethnicity in South Florida, 2012–2016
Black
White

All Black

Cancer type

African
American

Hispanic
AfroCaribbean

All Hispanic

Puerto Rican

Cuban

South
American

Other
Hispanicb

Age-Adjusted Mortality Rate Per 100,000 (95% Confidence Interval)

Ovary

7.3 (6.6–8.0)

5.7 (4.8–6.7)

6.0 (4.7–7.6)

5.3 (4.1–7.1)

4.9 (4.4–5.5)

5.5 (3.5–8.3)

5.6 (4.8–6.4)

4.8 (3.7–6.2)

3.3 (2.3–4.6)

Multiple
myeloma

2.0 (1.7–2.3)

4.2 (3.4–5.1)

3.7 (2.6–5.0)

4.6 (3.5–6.5)

2.0 (1.6–2.3)

2.3 (1.2–4.2)

1.9 (1.5–2.4)

2.4 (1.6–3.5)

1.6 (1.0–2.6)

132.6
133.4
164.1
(129.9–135.4) (128.9–138.1) (156.7–171.8)

106.2
(99.5–113.4)

92.9
(90.6–95.2)

103.0
(93.8–112.9)

97.1
(93.9–100.4)

91.6
(86.2–97.2)

84.5
(78.8–90.4)

All-sites- d
combined
a

Adjusted to the US 2000 standard population.
Includes decedents from Mexico, Central America, the Dominican Republic, and Spain.
c
Includes all ages.
d
All-sites-combined includes all cancers, including those not listed here.
e
Menopausal status approximated by use of age threshold of 50.
b
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Table 3. Mortality Rate Ratiosa for Selected Cancer Sites, by Race/Ethnicity, South Florida Compared With US Counterparts, Study on Patterns of Cancer Deaths by
Race/Ethnicity in South Florida, 2012–2014
White (Ref: US white)
Cancer type

All Black (Ref: US black)

African American (Ref: US black)

All Hispanic (Ref: US Hispanic)

Mortality Rate Ratio (95% Confidence Interval)

Male
Stomach

0.84 (0.71–0.99)

0.94 (0.76–1.15)

1.00 (0.74–1.32)

0.79 (0.68–0.92)

Colorectal

0.90 (0.83–0.98)

0.83 (0.73–0.94)

1.08 (0.93–1.27)

1.06 (0.97–1.16)

Liver, aged 50–69 y

1.23 (1.09–1.40)

0.48 (0.38–0.61)

0.69 (0.52–0.91)

0.48 (0.40–0.58)

Liver, aged ≥70 y

1.04 (0.91–1.19)

0.75 (0.53–1.06)

0.81 (0.50–1.31)

0.64 (0.53–0.76)

Pancreas

1.05 (0.91–1.13)

0.64 (0.54–0.77)

0.86 (0.69–1.07)

1.15 (1.03–1.28)

Lung

0.80 (0.77–0.83)

0.56 (0.51–0.61)

0.80 (0.72–0.89)

1.46 (1.38–1.55)

Prostate

0.81 (0.75–0.80)

0.99 (0.89–1.09)

1.16 (1.01–1.32)

1.16 (1.06–1.26)

Multiple myeloma

0.79 (0.68–0.92)

0.98 (0.79–1.21)

1.00 (0.74–1.36)

1.09 (0.90–1.32)

All-sites-combinedb

0.90 (0.87–0.91)

0.73 (0.70–0.76)

0.92 (0.87–0.97)

1.11 (1.08–1.14)

Stomach

0.94 (0.77–1.14)

1.10 (0.87–1.39)

1.19 (0.87–1.66)

0.79 (0.67–0.94)

Colorectal

0.88 (0.82–0.95)

0.89 (0.78–1.01)

1.00 (0.84–1.19)

1.15 (1.05–1.26)

Liver, aged 50–69 y

1.28 (1.02–1.60)

0.68 (0.48–0.98)

1.10 (0.73–1.65)

0.56 (0.42–0.74)

Liver, aged ≥70 y

1.06 (0.90–1.24)

0.83 (0.57–1.19)

0.71 (0.40–1.26)

0.70 (0.59–0.84)

Pancreas

1.04 (0.97–1.13)

0.73 (0.62–0.85)

0.90 (0.73–1.11)

0.98 (0.88–1.09)

Lung

0.96 (0.89–1.03)

0.58 (0.52–0.64)

0.91 (0.80–1.02)

1.13 (1.04–1.22)

Breast

0.94 (0.88–0.99)

0.89 (0.81–0.98)

1.12 (0.99–1.26)

1.06 (0.98–1.14)

Cervix

1.24 (1.02–1.50)

1.34 (1.08–1.66)

1.71 (1.30–2.23)

0.92 (0.75–1.13)

Endometrium

1.00 (0.88–1.13)

1.04 (0.89–1.23)

1.12 (0.90–1.40)

1.05 (0.90–1.22)

Ovary

0.99 (0.90–1.09)

0.89 (0.73–1.09)

1.02 (0.78–1.33)

1.02 (0.90–1.16)

Multiple myeloma

0.94 (0.81–1.11)

0.77 (0.61–0.97)

0.73 (0.52–1.03)

0.97 (0.79–1.18)

0.95 (0.91–0.98)

0.81 (0.78–0.85)

1.01 (0.95–1.06)

0.99 (0.96–1.03)

Female

b

All-sites-combined

Abbreviations: CI, confidence interval; MMR, mortality rate ratio; Ref, reference group.
a
MMRs derived from negative binomial regression including ages ≥35 except prostate and multiple myeloma, ≥45, and liver as described.
b
All-sites-combined includes all cancers, including those not listed here.
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